Singh, A., Jain, A., Balderman, S., Patil, S., Advani, A., Ali, M. M., Molina, J., Lucas, T., Cinalli, T., Mann, R., McCahon, L., Mukherjee, S., Gerds, A., Saunthararajah, Y., Maciejewski, J., Carraway, H., Jha, B., Adjei, A. (2025). A phase II study of eltrombopag in patients with low-risk MDS and CMML harboring TET2 mutations. Blood. https://doi.org/10.1182/blood-2025-2096